Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2500265 | Farmacia Hospitalaria | 2010 | 7 Pages |
Abstract
Although the duration of the first antiretroviral treatment remains short, currently fewer changes are made due to side effects and due to loss to follow-up. The reasons may be better tolerance and less complexity. However, more studies are needed to determine the benefits of one regimen or another, and to be able to generalise the results.
Related Topics
Health Sciences
Pharmacology, Toxicology and Pharmaceutical Science
Pharmaceutical Science
Authors
M.T. MartÃn, M. Rovira, M. Massanes, E. del Cacho, E. Carcelero, M. Tuset, C. Codina, J.M. Miro, J.M. Gatell, J. Ribas,